Decision day for lecanemab
Should lecanemab receive a green light from the FDA, it would be the second new Alzheimer’s therapy to come to market in two years.
Source: politico.com
📰 Jon Heppen News
Jon Heppen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jon Heppen. Real-time updates on events, politics, business and more.
The state of mental health and substance use in the U.S.
Nearly 94 percent of people with substance use disorder didn’t receive any treatment in 2021.
Source: politico.com